J.M. Scherrmann

1.7k total citations
53 papers, 1.4k citations indexed

About

J.M. Scherrmann is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Emergency Medicine. According to data from OpenAlex, J.M. Scherrmann has authored 53 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 9 papers in Radiology, Nuclear Medicine and Imaging and 8 papers in Emergency Medicine. Recurrent topics in J.M. Scherrmann's work include Monoclonal and Polyclonal Antibodies Research (7 papers), Poisoning and overdose treatments (6 papers) and Drug Transport and Resistance Mechanisms (6 papers). J.M. Scherrmann is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (7 papers), Poisoning and overdose treatments (6 papers) and Drug Transport and Resistance Mechanisms (6 papers). J.M. Scherrmann collaborates with scholars based in France, United States and Germany. J.M. Scherrmann's co-authors include A. Sabouraud, C Bismuth, Anthony Régina, M Debray, Frédéric J. Baud, Myriam Rochdi, Nicolas Perrière, Jamal Temsamani, Pierre Olivier Couraud and Jeanne-Marie Lefauconnier and has published in prestigious journals such as Neuroscience, Journal of Neurochemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

J.M. Scherrmann

50 papers receiving 1.3k citations

Peers

Countries citing papers authored by J.M. Scherrmann

Since Specialization

Citations

This map shows the geographic impact of J.M. Scherrmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.M. Scherrmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.M. Scherrmann more than expected).

Fields of papers citing papers by J.M. Scherrmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.M. Scherrmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.M. Scherrmann. The network helps show where J.M. Scherrmann may publish in the future.

Co-authorship network of co-authors of J.M. Scherrmann

This figure shows the co-authorship network connecting the top 25 collaborators of J.M. Scherrmann. A scholar is included among the top collaborators of J.M. Scherrmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.M. Scherrmann. J.M. Scherrmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pharmacokinetic simulations to explore dissolution criteria of BCS I and III biowaivers with and without MDR-1 efflux transporter 2014 ·European Journal of Pharmaceutical Sciences ·Hanna Kortejärvi, (unknown), Ramzi Shawahna, J.M. Scherrmann, Arto Urtti, Marjo Yliperttula	11
2	Iode stable et prévention de la contamination par les iodes radioactifs : données pharmacologiques et pharmaceutiques 2012 ·Annales Pharmaceutiques Françaises ·Benoît Hosten, N. Rizzo, J.M. Scherrmann, Vanessa Bloch	1
3	Effects of nitrous oxide on dopamine release in the rat nucleus accumbens and expectation of reward 2008 ·Neuroscience ·Nadia Benturquia, (unknown), J.M. Scherrmann, Florence Noble	14
4	Le fluor 18 en radiopharmacie 2008 ·Annales Pharmaceutiques Françaises ·Virginie de Beco, Daniel Le Bars, J.M. Scherrmann	4
5	Applications of a Blood-Brain Barrier Technology Platform to Predict CNS Penetration of Various Chemotherapeutic Agents. 1. Anti-Infective Drugs 2007 ·Chemotherapy ·(unknown), Nicolas Perrière, J.M. Scherrmann, Roger Lahana	3
6	Puromycin‐based purification of rat brain capillary endothelial cell cultures. Effect on the expression of blood–brain barrier‐specific properties 2005 ·Journal of Neurochemistry ·Nicolas Perrière, (unknown), Elizabeth García, Anthony Régina, M Debray, J P Andreux, Patrick Couvreur, J.M. Scherrmann, Jamal Temsamani, Pierre Olivier Couraud, Mária A. Deli, (unknown)	266
7	Functional expression of p-glycoprotein and multidrug resistance-associated protein (mrp1) in primary cultures of rat astrocytes 2000 ·Journal of Neuroscience Research ·(unknown), Anthony Régina, Jean Laplanche, (unknown), Bernadette Boval, Jean‐Marie Launay, J.M. Scherrmann	134
8	Interspecies Scaling of Clearance and Volume of Distribution for Horse Antivenom F(ab′)2 1998 ·Toxicology and Applied Pharmacology ·(unknown), (unknown), Guiying Hong, M Debray, J.M. Scherrmann	26
9	Pharmacokinetics of digoxin‐specific Fab: effects of decreased renal function and age 1997 ·British Journal of Clinical Pharmacology ·Claire Renard, (unknown), (unknown), Frédéric J. Baud, J.M. Scherrmann	16
10	Immunoreactivity and Pharmacokinetics of Horse Anti-Scorpion Venom F(ab′)–Scorpion Venom Interactions 1996 ·Toxicology and Applied Pharmacology ·(unknown), Charles Lutsch, (unknown), Jean Lang, J.M. Scherrmann	37
11	Role of P‐Glycoprotein in the Blood‐Brain Transport of Colchicine and Vinblastine 1996 ·Journal of Neurochemistry ·(unknown), Michel Lemaire, Jeanne-Marie Lefauconnier, J.M. Scherrmann	88
12	Interspecies Scaling of Clearance and Volume of Distribution for Digoxin-Specific Fab 1996 ·Toxicology and Applied Pharmacology ·(unknown), (unknown), M Debray, J.M. Scherrmann	27
13	Antibodies Proposed as Therapeutic Agents 1996 ·Archives of toxicology. Supplement ·C Bismuth, Frédéric J. Baud, Stephen W. Borron, J.M. Scherrmann	1
14	Efflux of intracellular colchicine in lymphocytes with colchicine-specific Fab fragments. 1995 ·Journal of Pharmacology and Experimental Therapeutics ·Olivier Chappey, Elisabeth Niel, M Debray, Jean‐Luc Wautier, J.M. Scherrmann	5
15	[Colchicine poisoning apropos of a pediatric case]. 1995 ·PubMed ·(unknown), (unknown), (unknown), J.M. Scherrmann, (unknown), G. Aulagner	6
16	Morphine Disposition in Opiate-Intoxicated Patients: Relevance of Nonspecific Opiate Immunoassays 1994 ·Journal of Analytical Toxicology ·(unknown), (unknown), P. Sandouk, (unknown), J.M. Scherrmann	6
17	The effect of colchicine-specific active immunization of colchicine toxicity and disposition in the rabbit 1989 ·Toxicology ·J.M. Scherrmann, M. Urtizberea, (unknown), (unknown)	26
18	Pharmacokinetics / bioavailability of colchicine in healthy male volunteers 1989 ·European Journal of Drug Metabolism and Pharmacokinetics ·(unknown), J.M. Scherrmann, M.O. Christen	28
19	Toxicokinetics of paraquat through the heart — lung block six cases of acute human poisoning 1988 ·Journal of Toxicology Clinical Toxicology ·Frédéric J. Baud, Pascal Houzé, C Bismuth, J.M. Scherrmann, Albert Jaeger, (unknown)	10
20	[Binding of delta-8-THC to human serum proteins: binding as a function of lipoprotein composition]. 1976 ·PubMed ·(unknown), Isabelle Treich, M Ayrault-Jarrier, H. Hoellinger, J.M. Scherrmann	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact